SCHEMBL669381

SCHEMBL669381

O=C1C(=O)C12CCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20854324 0.96 ESR1 (0.36)
SCHEMBL19628668 0.77 ESR1 (0.33)
SCHEMBL10485644 0.74 ESR1 (0.36)
SCHEMBL2640063 0.72 PGR (0.34)
SCHEMBL18020453 0.71 GSK3A (0.30)
SCHEMBL18020305 0.71 MAPT (0.31)
SCHEMBL2015391 0.69 ALDH1A1 (0.35)
SCHEMBL2982384 0.69 ALDH1A1 (0.33)
SCHEMBL22767562 0.69 ALDH1A1 (0.32)
SCHEMBL2015392 0.69 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2605762-A1 COMPOSITIONS COMPRISING ADIPOSE TISSUE AND A PGE2 ANALOGUE AND THEIR USE IN THE TREATMENT OF A SOFT TISSUE CONDITION Allergan, Inc. (US) 2013-06-26 EP disclosed
WO-2012024072-A1 COMPOSITIONS COMPRISING ADIPOSE TISSUE AND A PGE2 ANALOGUE AND THEIR USE IN THE TREATMENT OF A SOFT TISSUE CONDITION ALLERGAN, INC. (US) 2012-02-23 WO disclosed